Delivery Order SPE2DB20D2104-SPE2DB25FMYSL
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,103.07 firm fixed-price delivery order is for the supply of BRINZOLAMIDE 1% EYE DROPS 10ML, a pharmaceutical product. The contract has a period of performance through December 12, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $56,000 delivery order contract by the Defense Logistics Agency to supply brinzolamide 1% eye drops. The firm fixed price contract is for a single lot of the pharmaceutical product and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- This federal contract award, valued at $1,863.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRINZOLAMIDE 1% EYE DROPS 10ML, a medical product used for the treatment of various eye conditions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency Troop Support Medical awarded a $336,000 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4561863954 Brinzolamide 1% eye drops in 10mL bottles. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance spans from August 18, 2023 through August 21, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $2,880.44 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3mL) on August 19, 2025, with completion expected by August 20, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $2,555.92 delivery order from the Defense Logistics Agency (DLA) on August 7, 2025, for MIEBO 100% eye drop solution in 3 milliliter quantities. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing under a child delivery order mechanism. The place of performance is the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Logistics Agency awarded a $14,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Brimomidine 0.2% eye drops. Under this contract, Amerisourcebergen will deliver 5mL bottles of the eye drops to a location in Conshohocken, Pennsylvania by September 22, 2023. As a major provider of medical supplies and pharmaceuticals, Amerisourcebergen routinely supports the Defense Logistics Agency's mission to provide critical resources to military treatment facilities...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,649.80 to AmerisourceBergen Drug Corp for Lubricant 0.5% Eye Drop (30 units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $14,193.62 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop (3ml) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order carries no set-aside designation and reflects a competitive award to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYSLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,344.89 to AmerisourceBergen Drug Corp for the supply of Brinzolamine 1% eye drops (15mL) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was not set aside for any particular business category. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations as a major pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to military healthcare programs and other federal healthcare systems worldwide. AmerisourceBergen's established role as a critical federal pharmaceutical vendor is evidenced by its extensive portfolio of delivery orders covering diverse therapeutic domains, demonstrating the company's capability to fulfill diverse medical supply requirements across the Defense Health Agency and other government entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/22/25 |